P. D. de Sonnaville

发表

Evaluating Adherence to a Treat‐to‐Target Protocol in Recent‐Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation

C. Allaart, P. Kerstens, H. Ronday, 2016, Arthritis care & research.

Polyarticular heterotopic ossification complicating critical illness.

J. Jacobs, J. Bijlsma, P. D. de Sonnaville, 1999, Rheumatology.

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

D. van Zeben, A. Gerards, J. Luime, 2016, Rheumatology.

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

D. van Zeben, M. V. van Krugten, P. D. de Jong, 2016, Annals of the rheumatic diseases.

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.

J. D. de Vries-Bouwstra, C. Allaart, H. Guchelaar, 2006, Arthritis and rheumatism.

Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study

C. Allaart, T. Huizinga, K. Visser, 2013, Annals of the rheumatic diseases.

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

D. van Zeben, A. Gerards, M. V. van Krugten, 2014, Annals of the rheumatic diseases.

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.

D. van Zeben, A. Gerards, J. Luime, 2016, Rheumatology.

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

B. Dijkmans, Y. Goekoop-Ruiterman, J. D. de Vries-Bouwstra, 2009, Arthritis and rheumatism.

Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab

B. Dijkmans, C. Allaart, P. Kerstens, 2010, Annals of the rheumatic diseases.

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study

A. Gerards, T. Kvien, R. Feelders, 2012, Annals of the rheumatic diseases.

Comparison of Treatment Strategies in Early Rheumatoid Arthritis

B. Dijkmans, Y. Goekoop-Ruiterman, J. D. de Vries-Bouwstra, 2007, Annals of Internal Medicine.

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)

C. Allaart, H. Ronday, M. Westedt, 2012, Annals of the rheumatic diseases.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study

C. Allaart, T. Huizinga, T. Huizinga, 2013, Annals of the rheumatic diseases.

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

D. van Zeben, A. Gerards, J. Luime, 2012, Annals of the rheumatic diseases.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment

T. Stijnen, Y. Goekoop-Ruiterman, C. Allaart, 2016, Annals of Internal Medicine.

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)

Y. Goekoop-Ruiterman, C. Allaart, J. V. van Groenendael, 2016, Arthritis Research & Therapy.

Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria.

D. van Zeben, A. Weel, J. Luime, 2012, Rheumatology.

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study

C. Allaart, J. V. van Groenendael, T. Huizinga, 2017, Annals of the rheumatic diseases.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

D. van Zeben, S. Pluijm, J. Lindemans, 2013, Arthritis and rheumatism.

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

Y. Goekoop-Ruiterman, J. D. de Vries-Bouwstra, C. Allaart, 2009, Arthritis and rheumatism.